Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
---|
07/07/2011 | US20110165076 Novel [f-18]- labelled l-glutamic acid and l-glutamine derivatives (i), use thereof and method for their production |
07/07/2011 | US20110165075 Integrin targeting agents and in-vivo and in-vitro imaging methods using the same |
07/07/2011 | US20110165074 Chelating amphiphilic polymers |
07/07/2011 | US20110165073 Immunotherapy of b-cell malignancies using anti-cd22 antibodies |
07/07/2011 | US20110165072 Detection of Early-Stage Pancreatic Adenocarcinoma |
07/07/2011 | US20110165071 Methods Of Treating Cancer |
07/07/2011 | US20110165070 Methods for radiolabeling synthetic polymers |
07/07/2011 | US20110165069 Methods for radiolabeling macromolecules |
07/07/2011 | US20110165068 Liposome medicament, method of preparation and use thereof |
07/07/2011 | US20110165067 Carbohydrate functionalized catanionic surfactant vesicles for drug delivery |
07/07/2011 | US20110165066 Interleukin-13 binding proteins |
07/07/2011 | US20110165065 Means for the detection and treatment of prostate cells |
07/07/2011 | US20110165064 Methods and compositions related to clot-binding compounds |
07/07/2011 | US20110165063 Il-1 binding proteins |
07/07/2011 | US20110165062 Use of an anti-cd151 antibody for early treatment of cancer |
07/06/2011 | EP2340041A2 Porphyrazine optical and dual optical/mr contrast and therapeutic agents |
07/06/2011 | EP1588145B1 Methods, mixtures, kits and compositions pertaining to analyte determination |
07/06/2011 | CN102115474A Novel <18>F-marked pyrazolo[1,5-a]pyrimidine compound and preparation and application thereof |
07/05/2011 | US7972588 Radiolabelling methods |
07/05/2011 | CA2482327C Pendant fatty acid imaging agents |
07/05/2011 | CA2453845C Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
07/05/2011 | CA2439099C Anti-platelet and anti-thrombotic agents |
07/05/2011 | CA2373901C Sterile radioactive seeds |
06/30/2011 | WO2011078250A1 Radiolabeled compound directable in vivo to target tissue and use thereof |
06/30/2011 | WO2011077751A1 Composition for labeling tissues of central nervous system, method for labeling tissues of central nervous system, and screening method using the composition for labeling tissues of central nervous system |
06/30/2011 | WO2011077733A1 Transnasal labeling composition for tissues of central nervous system, and labeling method and screening method each using the transnasal labeling composition for tissues of central nervous system |
06/30/2011 | WO2011076825A1 Formulations suitable for pet imaging with hydrophobic pet agents |
06/30/2011 | WO2011076803A1 Measuring device and method for analysing a test gas by means of an infrared absorption spectroscopy |
06/30/2011 | WO2011041319A3 Specific binding proteins and uses thereof |
06/30/2011 | WO2011033112A3 68ga-labeled human serum albumin |
06/30/2011 | US20110159525 Methods to determine immunogenicity of humanized anti-tag 72 cc49 antibodies |
06/30/2011 | US20110158907 Diphenyl-heteroaryl derivatives and their use for binding and imaging amyloid plaques |
06/30/2011 | US20110158906 Targeted block copolymer micelles |
06/30/2011 | US20110158905 Dock-and-Lock (DNL) Complexes for Therapeutic and Diagnostic Use |
06/30/2011 | US20110158904 Antibodies that bind cell-associated ca 125/o772p and methods of use thereof |
06/30/2011 | US20110158903 One pot processes of preparing multifunctional liposome drug for imaging, delivery and targeting in cancer diagnosis and therapy |
06/30/2011 | US20110158902 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers |
06/30/2011 | US20110158901 Chitosan-based nanoparticles and methods for making and using the same |
06/30/2011 | DE102009060317A1 Tracking von Knochenmarkzellen für das Metastasenscreening Tracking of bone marrow cells for metastasis screening |
06/30/2011 | DE102009055321A1 Verfahren zur Bestimmung der Leberleistung eines Lebewesens mittels quantitativer Messung der Metabolisierung von Substraten A method of determining the liver function of a living being by means of quantitative measurement of the metabolism of substrates |
06/30/2011 | CA2785576A1 Formulations suitable for pet imaging with hydrophobic pet agents |
06/30/2011 | CA2785489A1 Measuring device and method for analysing a test gas by means of an infrared absorption spectroscopy |
06/29/2011 | EP2338892A1 Prostate specific membrane antigen inhibitors |
06/29/2011 | EP2338525A2 Remote detection of substance delivery to cells |
06/29/2011 | EP2338479A1 Radioactively marked microparticles, method for their manufacture and application thereof |
06/29/2011 | CN101555263B D-glucose dithiocarbamate complex marked by <99m>TcO, preparation method and applications thereof |
06/28/2011 | US7968511 Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple sclerosis |
06/28/2011 | US7968129 Cosmetic skin care complex with anti-aging effect |
06/28/2011 | US7968081 Peptide for diagnosing, preventing and treating atherosclerosis and uses thereof |
06/28/2011 | US7968080 Somatostatin analogs with inhibitory activity to growth hormone release |
06/28/2011 | CA2505142C Radioactive transition metal-imido hetero-diphosphine complexes, their preparation and radiopharmaceutical compositions thereof |
06/28/2011 | CA2483181C Method for obtaining a 2-18f-fluor-2-deoxy-d-glucose (18f-fdg) - solution |
06/28/2011 | CA2464002C Pacap compositions and methods for tumor imaging and therapy |
06/28/2011 | CA2259944C Melanoma associated peptide analogues and vaccines against melanoma |
06/23/2011 | WO2011073340A1 Labelled integrin binders |
06/23/2011 | WO2011073304A1 Aryloxyanilide imaging agents |
06/23/2011 | WO2011073286A1 Prostate specific membrane antigen inhibitors |
06/23/2011 | WO2011044410A3 Solid phase extraction purification method |
06/23/2011 | WO2011044406A3 Purification method |
06/23/2011 | WO2011017456A3 Localized delivery of nanoparticles for therapeutic and diagnostic applications |
06/23/2011 | US20110152193 Inhibitors of human plasmin derived from the kunitz domains |
06/23/2011 | US20110150938 Supercrystalline Colloidal Particles and Method of Production |
06/23/2011 | US20110150778 Assembly of Gas-Filled Microvesicle With Active Component For Contrast Imaging |
06/23/2011 | US20110150765 Frozen compositions and methods for piercing a substrate |
06/23/2011 | US20110150764 Stroke-tageting peptide and use thereof |
06/23/2011 | US20110150763 Triazine derivatives and their therapeutical applications |
06/23/2011 | US20110150762 Bone cement containing bone marrow |
06/23/2011 | US20110150760 PRLR-Specific Antibody and Uses Thereof |
06/23/2011 | US20110150759 Monoclonal antibody 175 tageting the egf receptor and derivatives and uses thereof |
06/23/2011 | US20110150758 Tracking of bone marrow cells for metastasis screening |
06/23/2011 | US20110150757 Compounds for inhibiting ksp kinesin activity |
06/23/2011 | CA2785064A1 Prostate specific membrane antigen inhibitors |
06/22/2011 | EP2336192A1 Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination |
06/22/2011 | EP2336187A2 Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations |
06/22/2011 | EP2336185A1 Anti- alpha v beta 6 antibodies |
06/22/2011 | EP2335739A1 Molecular probe precursor for imaging of pancreatic islet, and use thereof |
06/22/2011 | EP2335728A1 Specific binding proteins and uses thereof |
06/22/2011 | EP2334181A1 Phthalimide derivative metabotropic glutamate r4 ligands |
06/22/2011 | EP1204683B1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
06/22/2011 | CN102105174A Diagnostic agents selective against metalloproteases |
06/22/2011 | CN102100918A Evaluation method for disintegration dynamics process in plant shell vacant capsule |
06/22/2011 | CN101670120B Drug for diagnosis of gastric cancer and preparation method thereof |
06/22/2011 | CN101198359B Radioactive diagnostic imaging agent |
06/21/2011 | US7964703 DNAX Cytokine Receptor Subunits (DCRS) 5 cytokine receptors modulators; multiple sclerosis, rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, diabetes, psoriasis, sepsis or in allogeneic transplant; chronic Th1 mediated disease |
06/21/2011 | US7964644 Use of neurotoxic substances for the production of a means for the treatment of joint paint and method for application of said means |
06/21/2011 | US7964556 Antimicrobial peptides and use thereof |
06/21/2011 | US7964555 Contacting cardiac muscle cells with a neuregulin protein to activate the MAP kinase pathway in cardiac muscle cells and induce remodeling of cardiac muscle cell sarcomeric and cytoskeleton structures or cell-cell adhesions |
06/16/2011 | WO2011071083A1 Molecular probe for imaging of pancreatic islet, and use thereof |
06/16/2011 | WO2011070136A1 Iodine radiolabelling method |
06/16/2011 | WO2011070066A1 Fty720 halogenated derivatives |
06/16/2011 | WO2011048503A3 Peptides that bind the alpha-fetoprotein (afp) receptor and uses thereof |
06/16/2011 | WO2011044422A3 Solid phase extraction purification method |
06/16/2011 | US20110144483 Imaging agents |
06/16/2011 | US20110142760 Psma-binding agents and uses thereof |
06/16/2011 | US20110142759 Agents and methods for the imaging of myelin basic protein |
06/16/2011 | US20110142758 Indolyl-pyridazinyl-diazabicyclononane derivatives in labelled and unlabelled form and their use in diagnostic methods |
06/16/2011 | US20110142757 Novel compounds and their uses in diagnosis |
06/16/2011 | US20110142756 Method And Composition For The Treatment Of Cancer By The Enzymatic Conversion Of Soluble Radioactive Toxic Precipitates In The Cancer |
06/16/2011 | CA2780859A1 Fty720 halogenated derivatives |
06/15/2011 | EP2332576A1 Immunotherapy of B-cell malignancies using anti-CD22 antibody conjugates |